More News
19 September 2013
Activiomics Extends Research Agreement with Kyowa Hakko Kirin as Part of its Strategic Partnership with BioFocus19 September 2013
EpimiRNA Consortium Receives €11.5 Million Funding by EU to Uncover the Effects of microRNA in Epilepsy18 September 2013
Ferrer and Medivir enter agreement for commercializing a new treatment for agitation associated with schizophrenia and bipolar disease in the Nordics18 September 2013
EISAI’S U.S. RESEARCH SUBSIDIARY H3 BIOMEDICINE ENTERS INTO COLLABORATIVE AGREEMENT WITH SELVITA TO CREATE NOVEL ANTICANCER AGENTS13 September 2013
Mount Sinai Grants Exclusive License to Plexcera Therapeutics to Develop Treatments for Farber Disease and Cystic Fibrosis12 September 2013
Karo Bio Receives Funding from the National MS Society to Develop ERbeta Agonists for Treatment of Progressive Multiple Sclerosis12 September 2013
Evotec and Harvard Stem Cell Institute Form CureMN Collaboration to Advance ALS Research11 September 2013
Oxford BioMedica Wins Significant Funding via a Competitive Award from UK Government’s Advanced Manufacturing Supply Chain Initiative11 September 2013
AstraZeneca and Merck enter licence agreement for investigational oral WEE1 kinase inhibitor therapy for cancer10 September 2013
Bayer and the Broad Institute Join Forces to Develop Novel Treatment Options in Cancer Therapy9 September 2013
Biogen Idec and Isis Pharmaceuticals Announce Strategic Collaboration to Advance Treatment of Neurological Disorders9 September 2013
Sobi acquires full rights for Kineret(R) and additional clinical data for Kepivance(R) from Amgen6 September 2013
Nuclea Biotechnologies Inc. acquires WILEX Inc. and extends their cooperation with WILEX AG5 September 2013
Collaboration with Ultragenyx to Develop and Commercialize KRN23 for X-linked Hypophosphatemia4 September 2013
Johns Hopkins, Atherotech Announce Strategic Research Collaboration to Fight Heart DiseaseNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports